Cargando…
In vivo efficiency of praziquantel treatment of single-sex Schistosoma japonicum aged three months old in mice
Schistosomiasis is a major neglected tropical disease mainly caused by Schistosoma haematobium, S. japonicum and S. mansoni, and results in the greatest disease burden. Mass drug administration (MDA) with praziquantel (PZQ), a single drug only available for the disease, has played a vital role in sc...
Autores principales: | Wang, Ning, Peng, Han-Qi, Gao, Chang-Zhe, Cheng, Yu-Heng, Sun, Meng-Tao, Qu, Guo-Li, Webster, Joanne P., Lu, Da-Bing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9771832/ https://www.ncbi.nlm.nih.gov/pubmed/36403362 http://dx.doi.org/10.1016/j.ijpddr.2022.11.002 |
Ejemplares similares
-
Synergistic effect of combination chemotherapy with praziquantel and DW-3-15 for Schistosoma japonicum in vitro and in vivo
por: Yang, Zi-Yin, et al.
Publicado: (2021) -
New Insight into the Antifibrotic Effects of Praziquantel on Mice in Infection with Schistosoma japonicum
por: Liang, Yue-Jin, et al.
Publicado: (2011) -
Synthesis and SAR Studies of Praziquantel Derivatives with Activity against Schistosoma japonicum
por: Wang, Wen-Long, et al.
Publicado: (2013) -
In vitro and in vivo activities of DW-3-15, a commercial praziquantel derivative, against Schistosoma japonicum
por: Wang, Xiaoli, et al.
Publicado: (2019) -
Population Pharmacokinetics of Praziquantel in Pregnant and Lactating Filipino Women Infected with Schistosoma japonicum
por: Bustinduy, Amaya L., et al.
Publicado: (2020)